What is DaVita (DVA)?

DaVita (DVA) is a Stock on NASDAQ. This public tape shows delayed daily prices — not live quotes.

Is this live market data?

No. Tape shows delayed public daily prices. It is not investment advice. Live professional data is in the Stonks Ask terminal.

How do I research DVA in Stonks Ask?

Open the terminal and ask Stonks about DVA: business overview, recent price action, valuation, and what to watch next. Tape is the public delayed chart; the terminal adds live data and portfolio context.

DVA · DaVita — Tape

All tape

D

DVA NASDAQ

Following the Zacks article highlighting outpatient and home healthcare stocks, DaVita shows full-year revenue of $13.64 billion and a market cap of $11.81 billion. The company currently reports a trailing twelve-month EPS of 13.08 alongside a PE ratio of 15.82. Additionally, DaVita carries a free cash flow yield of 13.63%.

Based on zacks.com

1D1 day

5D5 days

1M1 month

6M6 months

YTDYear to date

1Y1 year

5Y5 years

AllAll time

zacks.comAug 28, 10:46 AM
4 Outpatient & Home Healthcare Stocks in Focus Amid Industry Tailwinds
fool.comAug 27, 01:03 PM
Warren Buffett and Greg Abel Quietly Hold a Bigger Percentage of This Company Than Any Other in Berkshire's Portfolio (Hint: It's Not Apple or American Express)
zacks.comAug 26, 10:31 AM
DVA & Humana Expand Value-Based Care for Kidney Disease Patients
prnewswire.comAug 26, 04:47 AM
Alebund Pharmaceuticals Announces 2026 Interim Results
prnewswire.comAug 25, 04:00 AM
DaVita Announces New Value-Based Partnership with Humana to Expand Care for Patients with Chronic Kidney Disease
defenseworld.netAug 25, 03:17 AM
2,460,987 Shares in DaVita Inc. $DVA Purchased by BlackRock Inc.

Market cap: 11.81B USD
Dividend yield: 0.00%
P/E: 15.82
Forward P/E: 11.95
Basic EPS (TTM): 13.08 USD
EPS (FY2026E): 14.85 USD
Net income (FY): 746.8M USD
Revenue (FY): 13.64B USD
Revenue (FY2026E): 14.09B USD
FCF yield (TTM): 13.63%
Shares float: —
Beta: —
52 week high
52 week low
Volume

Ticker: DVA
Exchange: NASDAQ
Type: Stock
Sector: —
ISIN: —

Revenue & Net Income (5Y)

EPS & Growth (5Y)

Free Cash Flow (5Y)

Capital Returns

Operating & Net Margin (5Y)

CapEx vs. Free Cash Flow (5Y)

Capital Allocation (5Y)

R&D and SG&A Intensity (5Y)

EBITDA (5Y)

Cost of Revenue (5Y)

Market Cap (5Y)

Ask Stonks with professional market data, charts beside chat, and your portfolio context.

Ask Stonks about DVA

Tape shows delayed public market data. Not investment advice.

DVA

D